市场概况

The global veterinary dermatology drugs market exhibits positive growth prospects, forecast to expand at a CAGR of 5.4% between 2023 和 2029 to reach USD 8.08 billion in value. Veterinary dermatology focuses on treating skin diseases and disorders in animal patients, covering both livestock and companion animals. While the COVID-19 pandemic resulted in disruptions, increased pet adoption and higher demand for companion animal care services provided upside.

Rising prevalence of dermatological illnesses in pets, coupled with growing pet ownership globally are key factors driving market growth. Skin conditions like atopic dermatitis have high incidence rates in dogs, spurring demand for veterinary drugs. Ongoing R&D focused on developing novel therapies also enhances market competitiveness.

然而, challenges like low availability of and awareness about specialized veterinary dermatology medicines in some regions may constrain uptake. Overcoming these through investments in product development and educational initiatives will be vital for long-term growth.

市场细分

The market is segmented based on animal, 给药途径, 指示, 分销渠道, 和地理.

Segmentation by Animal
Companion Animal
Livestock Animal

Segmentation by Route of Administration
Topical
可注射
口服

Segmentation by Indication
Parasitic Infections
Allergic Infections
Other Indications

分配通道分割
零售
Hospital Pharmacies
电子商务

按地理位置细分
北美 – 美国, 加拿大, 墨西哥
欧洲 – 英国, 德国, 法国, 意大利, 西班牙, 和欧洲其他地区
亚太 – 中国, 日本, 印度, 澳大利亚, 韩国, 以及亚太地区其他地区
拉美 – 巴西, 阿根廷, 和拉丁美洲其他地区
中东和非洲 – GCC, 南非, 以及中东和非洲其他地区

The companion animal segment is expected to dominate the veterinary dermatology drugs market. Companion animals, including dogs, cats, and other pets, are increasingly popular worldwide, leading to a higher demand for dermatological care. Skin infections and diseases are common in companion animals, especially in cats and dogs. Allergies, such as atopic dermatitis, are also on the rise in canines. The growing number of pets and the need for proper care drive the demand for dermatology drugs in this segment. Market players introducing new products for companion animals further contribute to market growth.

The oral route is the dominant method of drug administration in the studied market, projected to grow at a CAGR of 5.1%. It is preferred for its convenience, patient preference, cost-effectiveness, and ease of manufacturing. Hospital pharmacies are the primary distribution channel, expected to grow at a CAGR of 5.3%. They provide comprehensive healthcare services, including dispensing medications for acute infections.

The North American region is projected to witness high growth in the veterinary dermatology drugs market. This growth is attributed to the high prevalence of skin conditions in animals, such as pruritus, sores, alopecia, 还有更多. Factors driving market growth in developed countries like the United States and Canada include increased pet adoption, growing awareness about animal health, and higher expenditure on animal healthcare. Market players are launching new products and implementing strategic plans to contribute to market growth. The North American region is expected to experience significant growth in the veterinary dermatology drugs market during the forecast period.

竞争格局

The veterinary dermatology drugs market is moderately competitive, with a few key players. Mergers and acquisitions among market participants are increasing, leading to market growth. Major players are actively engaged in product development and strategic alliances to meet global demand and establish a strong industry position. Prominent companies in this market include Bimeda Holdings PLC, Bioiberica S.A.U., Ceva Animal Health, 有限责任公司, Elanco 动物保健公司, Indian Immunologicals Limited, LETI Pharma GmbH, 火星, 法人, 默克 & 公司。, 公司, Virbac Nutrition SAS, 硕腾公司, 除其他外.

最新行业发展

Animal Dermatology Group, 公司. acquired Animal Dermatology Referral Clinic in Dallas-Fort Worth in October 2022.

In the same month, Pet King Brands, 公司. expanded their ZYMOX Enzymatic Dermatology line with three new products targeting ear and skin issues in cats and kittens.

为什么选择这份报告

Gain a reliable outlook of the global veterinary dermatology drugs market forecasts from 2023 到 2029 跨场景.
确定投资的增长领域.
通过公司简介和市场数据领先于竞争对手.
Excel 格式的跨场景分析易用性的市场预估.
三个月的战略咨询和研究支持.
为单用户许可证提供打印验证.